Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Airway obstruction refers to any blockage that hinders the free flow of air through the respiratory tract. It can occur in either the upper or lower parts of the airway. Causes include swelling and mucus production from conditions like asthma or COPD, foreign bodies (such as food or toys), trauma, allergic reactions, burns, chemicals, and congenital abnormalities. Symptoms may include coughing, wheezing (especially with lower airway involvement), stridor (with upper airway involvement), shortness of breath, rapid breathing and heartbeat. Severe cases can lead to agitation, loss of consciousness or death if untreated. Diagnosis often involves clinical assessment and tests such as spirometry for chronic cases. Treatment depends on cause but may involve removing blockages physically or medically using bronchodilators or anti-inflammatory drugs; severe cases require urgent intervention including oxygen therapy and sometimes mechanical ventilation.
Bronchodilators relax and widen airways to improve airflow. Inhaled corticosteroids decrease inflammation in the airways.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Airway obstruction.